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To obtain credit, you should ? rst read the journal article. After reading the article, you should be able to answer the 
following, related, multiple-choice questions. To complete the questions and earn continuing medical education (CME) 
credit, please go to http://www.medscape.com/cme/eid. Credit cannot be obtained for tests completed on paper, although 
you may use the worksheet below to keep a record of your answers. You must be a registered user on Medscape.com. If 
you are not registered on Medscape.com, please click on the New Users: Free Registration link on the left hand side of 
the website to register. Only one answer is correct for each question. Once you successfully answer all post-test ques-
tions you will be able to view and/or print your certi? cate. For questions regarding the content of this activity, contact 
the accredited provider, CME@medscape.net. For technical assistance, contact CME@webmd.net. American Medical 
Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in 
CME activities. For further information on this award, please refer to http://www.ama-assn.org/ama/pub/category/2922.
html. The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible 
for AMA PRA Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA 
PRA credit is acceptable as evidence of participation in CME activities. If you are not licensed in the US and want to 
obtain an AMA PRA CME credit, please complete the questions online, print the certi? cate and present it to your national 
medical association.
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CME Questions
Activity Evaluation
1. Which of the following organisms is most likely to 
have been reported as a contaminant associated with 
betamethasone injection?
A. Sphingomonas paucimobilis
B. Serratia marcescens
C. Pseudomonas putida
D. Exophiala spp.
2. Which of the following is least likely to be an 
accurate description of S. paucimobilis?
A.   Gram-positive
B.   Glucose-nonfermenting
C.   Yellow-pigmented
D.   Found in soil and water
3. In this case series, which of the following was 
investigated as a source of exposure to fentanyl that 
resulted in S. paucimobilis bacteremia infection in 
patients?
A.  Intravenous infusions
B.   Contrast agents
C.   Medications
D.   All of the above
4. Which of the following strategies was recommended 
by the study authors to reduce the incidence of 
bacterial contamination by compounding pharmacies?
A.   Inspect source of drugs before preparation
B.   End-product sterility testing
C.   Elimination of compounding pharmacies
D.   None of the above
1. The activity supported the learning objectives. 
Strongly Disagree Strongly Agree 
1 5 4 3 2
2. The material was organized clearly for learning to occur.
Strongly Disagree Strongly Agree
5 4 3 2 1
3. The content learned from this activity will impact my practice.
Strongly Disagree Strongly Agree
5 4 3 2 1
4. The activity was presented objectively and free of commercial bias.
Strongly Disagree Strongly Agree
5 4 3 2 1
Nationally distributed medications from compounding 
pharmacies, which typically adhere to less stringent quality-
control standards than pharmaceutical manufacturers, can 
lead to multistate outbreaks. We investigated a cluster of 
6 patients in a Maryland hospital who had Sphingomonas
paucimobilis bloodstream infections in November 2007. Of 
the 6 case-patients, 5 (83%) had received intravenous fen-
tanyl within 48 hours before bacteremia developed. Cultures 
of unopened samples of fentanyl grew S. paucimobilis; the 
pulsed-ﬁ  eld gel electrophoresis pattern was indistinguish-
able from that of the isolates of 5 case-patients. The con-
taminated fentanyl lot had been prepared at a compound-
ing pharmacy and distributed to 4 states. Subsequently, in 
California, S. paucimobilis bacteremia was diagnosed for 
2 patients who had received intravenous fentanyl from the 
same compounding pharmacy. These pharmacies should 
adopt  more  stringent  quality-control  measures,  including 
prerelease product testing, when compounding and distrib-
uting large quantities of sterile preparations.
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Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity 
to earn CME credit. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for 
physicians. Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only 
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content; (3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certi? cate.
Learning Objectives
Upon completion of this activity, participants will be able to:
Describe the types of bacterial contamination associated with different compounding pharmacy medications. • 
Describe the features of  •  Sphingomonas paucimobilis bacteria.
Identify the types of exposure associated with transmission of  •  S. paucimobilis infection with contaminated fentanyl.
Describe a strategy that would limit the occurrence of compounding pharmacy product contamination. • 
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